Skip to main content
Top

Current Atherosclerosis Reports

Issue 6/2022

Content (9 Articles)

Cardiometabolic Disease and Treatment (R. Santos, Section Editor)

Genetic and Mechanistic Insights into the Modulation of Circulating Lipoprotein (a) Concentration by Apolipoprotein E Isoforms

Kévin Chemello, Dirk J. Blom, A. David Marais, Gilles Lambert, Valentin Blanchard

Hypercholesterolemia Cardiometabolic Disease and Treatment (R. Santos, Section Editor)

Updates on the Use of Subclinical Atherosclerosis to Predict Risk of Cardiovascular Events in Heterozygous Familial Hypercholesterolemia

Antonio Gallo, Reed Mszar, Marcio Hiroshi Miname

Hypercholesterolemia Cardiometabolic Disease and Treatment (R. Santos, Section Editor)

Monogenic Versus Polygenic Forms of Hypercholesterolemia and Cardiovascular Risk: Are There Any Differences?

Erin Jacob, Robert A. Hegele

Hypercholesterolemia Cardiometabolic Disease and Treatment (R. Santos, Section Editor)

Familial Hypercholesterolemia and Lipoprotein(a): Two Partners in Crime?

Rodrigo Alonso, Rosa Argüeso, Pilar Álvarez-Baños, Ovidio Muñiz-Grijalvo, Jose Luis Diaz-Diaz, Pedro Mata

Heart Failure Cardiometabolic Disease and Treatment (R. Santos, Section Editor)

Glycated Hemoglobin as an Integrator of Cardiovascular Risk in Individuals Without Diabetes: Lessons from Recent Epidemiologic Studies

Alexander P. Hoffmann, Michael C. Honigberg

Coronary Heart Disease (S. Virani and M. Al Rifai, Section Editors)

Next Generation Risk Markers in Preventive Cardio-oncology

Morgan Lamberg, Andrea Rossman, Alexandra Bennett, Sabrina Painter, Rachel Goodman, James MacLeod, Ragasnehith Maddula, David Rayan, Krishna Doshi, Alexander Bick, Simone Bailey, Sherry-Ann Brown

Dabigatran Coronary Heart Disease (S. Virani and M. Al Rifai, Section Editors)

DOACs and Atherosclerotic Cardiovascular Disease Management: Can We Find the Right Balance Between Efficacy and Harm

Feng Gao, Faisal Rahman

Hypercholesterolemia Children/Adolescents/Young Adults and Atherosclerosis (D.P. Wilson, Section Editor)

Are Clinicians Aggressive Enough in Treating Diabetes-Related Hyperlipidemia in Youth?

Sarah Jackson, Ana Creo, Seema Kumar

Arterial Occlusive Disease Genomics and Genomics (R.A. Hegele and L. Brunham, Section Editors)

More than Just a Monolayer: the Multifaceted Role of Endothelial Cells in the Pathophysiology of Atherosclerosis

Marion Mussbacher, Klaudia Schossleitner, Julia B. Kral-Pointner, Manuel Salzmann, Astrid Schrammel, Johannes A. Schmid

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.